Atrial fibrillation: current aspects of pathogenesis and treatment
Clinical review for general practice · 19.01.2026 · 6 (12) · 106-114
DOI: 10.47407/kr2025.6.12.00738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 19.01.2026. Verfasst von Dmitry I Trukhan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Atrial fibrillation is the most common sustained cardiac arrhythmia worldwide and is associated with a significantly increased risk of ischemic stroke, myocardial infarction, heart failure, and all-cause mortality. Periodontal disease is among the most common human diseases. At the beginning of the 21st century, the concept of "periodontal medicine" emerged, examining the relationship between periodontal pathology and other diseases. In the first part of this review, based on a search of the PubMed database of sources published before November 15, 2025, we examine the relationship between atrial fibrillation and periodontal pathology. The data obtained demonstrate a pathogenetic link, confirmed by experimental and clinical studies, between periodontal pathology, primarily periodontitis, and the development and progression of atrial fibrillation. Possible mechanisms linking periodontitis and atrial fibrillation are discussed. These include chronic immune activation, proinflammatory cytokines, autoimmune reactions, atrial fibrosis, and the direct effects of oral periodontal pathogens (e.g., Porphyromonas gingivalis) on myocardial tissue. Non-surgical periodontal therapy and improved oral hygiene significantly reduce the level of inflammatory markers and the risk of developing and progressing atrial fibrillation, allowing periodontal pathology and oral health to be considered a modifiable risk factor. The second part of the review examines publications from 2025 on drug-based antiarrhythmic therapy, confirming the relevance of its safety. Keywords: atrial fibrillation, periodontal pathology, periodontitis, systemic inflammation, Porphyromonas gingivalis, comorbidity, safety of antiarrhythmic therapy, amiodarone, propafenone comorbidity.
Zitieren
APA
Trukhan, D. I., Sulimov, A. F., Trukhan, L. Y., & Rozhkova, M. Y. (2026). Atrial fibrillation: current aspects of pathogenesis and treatment. Clinical review for general practice, 6(12), 106-114. https://doi.org/10.47407/kr2025.6.12.00738
Vancouver
Trukhan DI, Sulimov AF, Trukhan LY, Rozhkova MY. Atrial fibrillation: current aspects of pathogenesis and treatment. Clinical review for general practice. 2026;6(12):106-114. doi:10.47407/kr2025.6.12.00738
BibTeX
@article{Trukhan2026,
author = {Trukhan, Dmitry I and Sulimov, Anatoly F and Trukhan, Larisa Yu and Rozhkova, Maria Yu},
title = {Atrial fibrillation: current aspects of pathogenesis and treatment},
journal = {Clinical review for general practice},
year = {2026},
volume = {6},
number = {12},
pages = {106--114},
doi = {10.47407/kr2025.6.12.00738}
}
EUVIMED